QualityStocks News Alert
SeriousTraders Monthly 8/1/10


This Month Includes:

Cellceutix Corp. (OTCBB: CTIX)
Uranium Energy Corp (NYSE AMEX: UEC)



Cellceutix Corp. (OTCBB: CTIX)

Cellceutix Corp. (OTCBB: CTIX) is an emerging bio-pharmaceutical company focused on developing small-molecule therapies for treating cancers, autism and inflammatory diseases. Unlike many other small biotech companies which are working on only one drug, the company has a portfolio of 8 promising new compounds. Two of these in particular are drawing attention from both the medical and investment communities.

The company's flagship compound is Kevetrin, which is being developed to treat multi-drug resistant cancers. Most cancer drugs today are derivatives of already existing drugs. This is the main reason why standard cancer chemotherapy treatments today can be ineffective as the cancers develop a resistance to these drugs. Kevetrin, however, is a 100% unique drug that is unrelated to existing drugs on the market. This should make it effective on drug-resistant cancers, which investors are very excited about.

The next exciting drug Cellceutix is working on is KM-391, a treatment for autism. This compound is revolutionary in that it addresses the core issues of autism. Current drugs on the market only treat the symptoms that arise from autism. In the autistic brain, neonatal serotonin deletion and decreased brain plasticity are observed. Preliminary testing of KM-391 on animals showed a significant increase in serotonin uptake with noticeable and measurable positive therapeutic changes. Increased serotonin levels were seen in all three areas of the brain – cerebral cortex, hippocampus and caudate nucleus. Cellceutix is rapidly developing KM-391 in response to the public outcries for help.

Cellceutix has leading figures in the health and science fields onboard to lead the development efforts of their promising compounds. With over a century of combined experience, this team has been assembled with the specific goal of revolutionizing much needed treatments for some of today's most challenging diseases.




Uranium Energy Corp.

Uranium Energy Corp. (NYSE AMEX: UEC) is an exploration and mining company that is focused on properties in the United States that have the potential to contain uranium. Its objective is near-term uranium production using advanced, low-cost in-situ recovery methods. The company's primary uranium mining projects are located in Texas and New Mexico.

The United States has a quarter of the world's nuclear reactors. These reactors burn through 55 million pounds of uranium annually producing much-needed electricity. Yet, only 3.5 million pounds of uranium are mined here in the United States. That output comes from the nation's only four active uranium mines. UEC has plans to change that.

Decades ago, the search for uranium deposits turned up millions of pounds in states like Texas. But the price of uranium and uranium mining in the United States collapsed following the accidents at Three Mile Island and Chernobyl and the cancellation of 100 planned nuclear reactors in the United States. Subsequently, much of the uranium supply of the past couple decades came from decommissioned Russian nuclear warheads, but that source is drying up. Freshly mined uranium largely comes from geopolitically unstable regions of the globe such as Niger and Kazakhstan.

However, the nuclear industry is currently enjoying a renaissance. Earlier this year, the Obama Administration announced more than $8 billion in federal loan guarantees for the construction of the first nuclear power plant in the United States in nearly three decades. Overall, the loan guarantee program will be tripled to $54 billion which could lead to the construction of a dozen or so nuclear reactors. UEC's timing to begin mining uranium appears to be impeccable.

Uranium Energy Corporation believes it can start production at its mine in Duval County, Texas by the end of 2010. Its goal is to get even more mining permits at additional locations and to reach 2.5 million to 3 million pounds of uranium production a year within five years. Unlike many of its peers, UEC has a clear path to producing uranium profitably and sufficient cash on hand to begin mining. With spot uranium prices hovering in the $40s per pound and with some electric utilities paying closer to $60 a pound in longer-term contracts, UEC's mines should become very profitable.





eDOORWAYS Corp. (PINKSHEETS: EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. By uniting consumers with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes "dynamic" commerce, as opposed to the static model currently in existence.

The first half of the year has seen continued expansion of website functionality, including the deployment of PowerChannels as a major opportunity for growth and revenue. These PowerChannels are essentially highly focused, collaborative social networks that are formed to accomplish a specific communication objective that can be business-oriented, recreational, or purely personal.

Other areas of activity include the company's largest client, ISTEC (Ibero-American Science, Technology and Education Consortium), which is in the first stage of migrating its many members to the eDoorways platform. ISTEC enjoys a strong working alliance with two international organizations, both of which have global conferences later this year that eDoorways will attend.

In recent news, the company announced that it has engaged InvestorsVoice, Inc. to assist in its ongoing efforts to communicate with the investment community. InvestorsVoice, a multi-faceted investor relations, communications, and public relations firm, will provide existing and potential investors the opportunity to learn more about eDoorways, either directly or through investment advisors.




Home | Clients | About Us | Contact Us | Disclaimer
Copyright 2008-2010 SeriousTraders
3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251